Skip to main content
星昊医药 logo

星昊医药 — Investor Relations & Filings

Ticker · 920017 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 417 across all filing types
Latest filing 2023-11-22 Board/Management Inform…
Country CN China
Listing Beijing Stock Exchange 920017

About 星昊医药

https://www.sunho.com.cn/

Beijing Sunho Pharmaceutical Co., Ltd. is a technology-driven enterprise specializing in the research, development, manufacturing, and commercialization of advanced pharmaceutical preparations. The company focuses on high-barrier drug delivery systems, including sustained-release, controlled-release, and complex injection technologies. Its core business encompasses the production of a diverse portfolio of chemical drugs and biological products, alongside comprehensive Contract Development and Manufacturing Organization (CDMO) services. Sunho Pharmaceutical operates modern, GMP-compliant production facilities designed to support the entire lifecycle of drug development, from pilot-scale testing to large-scale commercial manufacturing. By leveraging its proprietary formulation platforms, the company provides integrated solutions for complex dosage forms, catering to both domestic and international pharmaceutical markets.

Recent filings

Filing Released Lang Actions
独立董事候选人声明与承诺
Board/Management Information Classification · 95% confidence The document is a declaration and commitment statement by an independent director candidate for Beijing Xinghao Pharmaceutical Co., Ltd. It details the candidate's qualifications, compliance with relevant laws and regulations, and commitment to independence and duties. There is no financial data, no report or announcement of financial results, no voting results, no management changes, and no regulatory filings of other types. This document is a formal statement related to board/management information, specifically about a director candidate's declaration and commitment. Therefore, the most appropriate classification is Board/Management Information (MANG). The document length is short but contains substantive content about management (director candidate) information, not just an announcement or notice.
2023-11-22 Chinese
董事会议事规则
Governance Information Classification · 100% confidence The document is titled "北京星昊医药股份有限公司董事会议事规则" which translates to "Beijing Xinghao Pharmaceutical Co., Ltd. Board Meeting Rules." It details the rules and procedures governing the company's board of directors meetings, including composition, powers, meeting notices, voting procedures, and record-keeping. It is a governance document outlining internal rules and board structure rather than a financial report, announcement of voting results, or management change. There is no indication of financial data, audit opinions, or shareholder meeting results. The document is comprehensive and over 8,000 characters, indicating it is the actual governance rules document, not a brief announcement or summary. Therefore, it fits the category of Governance Information (CGR).
2023-11-22 Chinese
第六届董事会第十九次会议决议公告
Board/Management Information Classification · 100% confidence The document is a detailed announcement of resolutions passed at the 19th meeting of the 6th Board of Directors of Beijing Xinghao Pharmaceutical Co., Ltd. It includes information about meeting attendance, voting results, and various governance-related proposals such as amendments to the company charter, board rules, and appointment of an independent director. The document references multiple governance documents and policies disclosed on the Beijing Stock Exchange information platform. There is no financial data or quarterly/annual report content. The focus is on board decisions and governance matters. Therefore, this document fits best under Board/Management Information (MANG) as it announces board meeting resolutions and management decisions.
2023-11-22 Chinese
第七届监事会第八次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolution passed at the eighth meeting of the seventh Supervisory Board of Beijing Xinghao Pharmaceutical Co., Ltd. It details the meeting date, attendance, agenda, and voting results on a proposal to amend the company's Articles of Association. The document is an official announcement of board/management decisions and changes related to corporate governance but does not contain financial statements or detailed management reports. It is not a full annual or interim report, nor is it a regulatory filing or proxy solicitation. The content fits best under Board/Management Information (MANG) as it announces board meeting resolutions and governance-related decisions.
2023-11-22 Chinese
独立董事制度
Governance Information Classification · 100% confidence The document is a detailed corporate governance policy titled '独立董事制度' (Independent Director System) issued by Beijing Xinghao Pharmaceutical Co., Ltd. It outlines the rules, qualifications, duties, nomination, election, and rights of independent directors. The document includes references to company law, securities regulations, and stock exchange rules, and it is signed by the company's board of directors. It is not a financial report, earnings release, or announcement of voting results. It is a governance-related document detailing internal rules and board structure. Therefore, it fits the category of Governance Information (CGR). The document length (9466 characters) and content confirm it is the full policy, not just an announcement or summary.
2023-11-22 Chinese
关于召开2023年第六次临时股东大会通知公告（提供网络投票）
Regulatory Filings Classification · 95% confidence The document is a notice announcing the convening of the 2023 sixth extraordinary general meeting of shareholders (临时股东大会通知公告). It details the meeting date, voting methods (including online voting), agenda items to be discussed, and procedural information for shareholders. It does not contain actual voting results or financial data, nor is it a report or transcript. The document is an announcement related to a shareholders meeting, specifically a notice of the meeting itself, not the results or materials presented. Therefore, it fits best under the category of Declaration of Voting Results & Voting Rights Announcements (DVA) if it contained results, but since it is a notice of the meeting, it is more aligned with Regulatory Filings (RNS) as a general regulatory announcement. However, since the document is a formal notice of a shareholders meeting (临时股东大会通知公告), which is a type of shareholder meeting notice, and not a voting result or proxy solicitation, the best fit is Regulatory Filings (RNS). The document length is 3327 characters, which is short and consistent with an announcement rather than a full report. Hence, the classification is RNS with high confidence.
2023-11-22 Chinese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.